Skip to main content
SpringerLink
Log in
Book cover

Non-Myeloablative Allogeneic Transplantation pp 177–211Cite as

Non-Myeloablative Transplants for Congenital Diseases

  • Chapter

  • 61 Accesses

Part of the book series: Cancer Treatment and Research ((CTAR,volume 110))

Abstract

The morbidity and mortality associated with postnatal HSCT, toxicity of HSCT conditioning regimens, lifelong immunosuppressive therapy, and lack of compatible donors discourages many patients and physicians from utilizing postnatal HSCT as a treatment for congenital disease. Non-myeloablative in utero HSCT is now being considered as an alternate treatment with the hope that it will be more therapeutic with less toxicity to a wider spectrum of patients with congenital disorders. Prenatal stem cell transfer may eliminate many of the risks and hazards associated with postnatal HSCT, as the fetus may be less reactive than an immunologically mature individual such that tolerance to donor cells could be developed. GVHD and rejection of postnatal therapeutic grafts may be minimized thus reducing or eliminating altogether the need for postnatal myeloablation and immunosuppression. Much work must be done both in animal studies as well as in clinical trials. By using well-designed murine models such as the β-thalassemic mouse outlined above, we believe we can determine the optimal conditions for non-myeloablative postnatal transplants with allogeneic or haplocompatible HSC following prenatal tolerance induction with these cells. In addition, we may answer basic immunology questions regarding the development and regulation of immunity and tolerance in both mice and humans.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Krivit W, Shapiro E, Kennedy W et al: Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation. New Engl J Med. 322(1):28, 1990

    Article  PubMed  CAS  Google Scholar 

  2. Krivit W, Pierpont ME, Ayaz K et al: Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis VI). Biochemical and clinical status 24 months after transplantation. New Engl J Med. 311(25):1606, 1984

    Article  PubMed  CAS  Google Scholar 

  3. Parkman R: The application of bone marrow transplantation to the treatment of genetic diseases. Science 232(4756):1373, 1986

    Article  PubMed  CAS  Google Scholar 

  4. Sullivan KM: Current status of bone marrow transplantation. Transplant Proc. 21(3 Suppl 1):41, 1989

    PubMed  CAS  Google Scholar 

  5. Clark J: The challenge of bone marrow transplantation. Mayo Clin Proc. 65(1):111, 1990

    PubMed  CAS  Google Scholar 

  6. Sasazuki T, Juji T, Morishima Y et al: Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. New Engl J Med. 339(17):1177, 1998

    Article  PubMed  CAS  Google Scholar 

  7. Exner BG, Acholonu I, Ildstad ST: Hematopoietic chimerism, tolerance induction and graft-versus-host disease: considerations for composite tissue transfer. Transplant Proc. 30(6):2718, 1998

    Article  PubMed  CAS  Google Scholar 

  8. Ellison C, Gartner J: Acute, lethal graft-versus-host disease in a F1-hybrid model using grafts from parental-strain, T-cell receptor-delta gene knockout donors. Scand J Immunol. 48(3):272, 1998

    Article  PubMed  CAS  Google Scholar 

  9. Asplund S, Gramlich TL: Chronic mucosal changes of the colon in graftversus-host disease. Mod Pathol. 11(6):513, 1998

    PubMed  CAS  Google Scholar 

  10. Nagler A, Condiotti R, Nabet C et al: Selective CD34+-T cell depletion does not prevent graft-versus-host disease. Transplantation 66(1):138, 1998

    Article  PubMed  CAS  Google Scholar 

  11. Klingebiel T, Schlegel PG: GVHD: overview on pathophysiology, incidence, clinical and biological features. Bone Marrow Transplant 21(Suppl 2):S45, 1998

    PubMed  Google Scholar 

  12. Rebecca H. Buckley, Sherrie E. Schiff, Richard I. Schiff, M. Louise Markert, Larry W. Williams, Joseph L. Roberts, Laurie A. Myers, Frances E. Ward Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined Immunodeficiency. The New England Journal of Medicine, February 18, 1999,Vol. 340, No. 7 N Engl J Med 1999;340:508–16.

    CAS  Google Scholar 

  13. Giardini C, Lucarelli G. Bone marrow transplantation for beta-thalassemia. Hematol Oncol Clin North Am 1999, Oct 13 (5): 1059.

    Article  PubMed  CAS  Google Scholar 

  14. Lucarelli G, Galimberti M, Giardini C, Polchi P, Angelucci E, Baronciani D, Erer B, Graziev D: Bone marrow transplantation in thalassemia. The experience of Pesaro. Ann NY Acad Sci 850:270, 1998

    Article  PubMed  CAS  Google Scholar 

  15. Lucarelli G, Clift RA, Galinberti M et al: Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood 87(5):2082, 1996

    PubMed  CAS  Google Scholar 

  16. Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Ferrant A, Zenebergh A, Maes P, Dhooge C, Benoit Y, Beguin Y, Dresse MF, Sariban E Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium.Bone Marrow Transplant1998 Jul;22(1):1–6

    CAS  Google Scholar 

  17. Charles Peters, Elsa G. Shapiro, James Anderson, P. Jean Henslee-Downey, Martin R. Klemperer, Morton J. Cowan, E. Fred Saunders, Pedro A. deAlarcon, Clare Twist, James B. Nachman, Gregory A. Hale, Richard E. Harris, Marta K. Rozans, Joanne Kurtzberg, Guy H. Grayson, Thomas E. Williams, Carl Lenarsky, John E. Wagner, William Krivit, and the members of The Storage Disease Collaborative Study Group. Hurler Syndrome: II. Outcome of HLAGenotypically Identical Sibling and HLA-Haploidentical Related Donor Bone Marrow Transplantation in Fifty-Four Children: Blood, Vol. 91 No. 7 (April 1), 1998: pp. 2601–2608.

    Google Scholar 

  18. Tavassoli M. Embryonic and fetal hemopoiesis: an overview. Blood Cells 1991;1:269–81

    Google Scholar 

  19. Renda MC, Fecarotta E, Dieli F, Markling L, Westgren M, Damiani G, Jakil C, Picciotto F, Maggio A: Evidence of alloreactive T lymphocytes in fetal liver: implications for fetal hematopoietic stem cell transplantation.Bone Marrow Transplant2000 Jan;25(2):135–41.

    Article  PubMed  CAS  Google Scholar 

  20. Blazar BR, Taylor PA, Vallera DA: In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities. Blood 86(11):4353, 1995

    PubMed  Google Scholar 

  21. Archer DR, Turner CW, Yeager AM, Fleming WH: Sustained multilineage engraftment of allogeneic hematopoietic stem cells in NOD/SCID mice after in utero transplantation. Blood 90:3222, 1997

    PubMed  CAS  Google Scholar 

  22. Bruce R. Blazar, Patricia A. Taylor, Ron McElmurry, Lina Tian, Angela Panoskaltsis-Mortari, Sylvia Lam, Chris Lees, Thomas Waldschmidt, and Daniel A. Valiera: Engraftment of Severe Combined Immune Deficient Mice Receiving Allogeneic Bone Marrow Via In Utero or Postnatal Transfer. Blood, Vol. 92 No. 10 (November 15), 1998: pp. 3949–3959

    Google Scholar 

  23. Fleischman R, Mintz B: Prevention of genetic anemias in mice by microinjection of normal hematopoietic cells into the fetal placenta. Proc Natl Acad Sci USA 76:5736, 1979

    Article  PubMed  CAS  Google Scholar 

  24. Blanchet JP, Fleischman RA, Mintz B: Murine adult hematopoietic cells produce adult erythrocytes in fetal recipients. Developmental Genetics 3:197, 1982

    Article  CAS  Google Scholar 

  25. Blazar BR, Taylor PA, Valiera DA: Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients. Blood 85(3):833, 1995

    PubMed  CAS  Google Scholar 

  26. Soper BW, Duffy T, Barker JE: Corrective therapy for mucopolysaccharidosis type VII by transplantation of syngeneic lineagelowSCA-lDghighhoecHSCT 33342lowmarrow into W41/W41/gusmps/gusmpsrecipients. Blood 90(10):364a, 1997

    Google Scholar 

  27. Zanjani ED, Almeida-Porada G, Flake AW: The human/sheep xenograft model: a large animal model of human hematopoiesis.Int J Hematol1996Apr;63(3):179–92

    Article  PubMed  CAS  Google Scholar 

  28. Zanjani ED, Ascensao JL, Flake AW, Harrison MR, Tavassoli M: The fetus as an optimal donor and recipient of hemopoietic stem cells. Bone Marrow Transplant 10:107, 1992 (suppl 1)

    Google Scholar 

  29. Mychaliska GB, Rice HE, Tarantal AF et al: In utero hematopoietic stem cell transplants prolong survival of postnatal kidney transplantation in monkeys. J Pediatr Surg. 32(7):976, 1997

    Article  PubMed  CAS  Google Scholar 

  30. Flake AW and Zanjani ED: In Utero Hematopoietic Stem Cell Transplantation: Ontogenic Opportunities and Biological Barriers. Blood (94) 7: 2179–2191, October 1, 1999.

    Google Scholar 

  31. Touraine JL, Raudrant D, Rebaud A, Roncarolo MG, Laplace S, Gebuhrer L, Betuel H, Frappaz D, Freycon F, Zabot MT, Dubernard JM: In utero transplantation of stem cells in humans: Immunological aspects and clinical follow-up of patients. Bone Marrow Transplant 1:121, 1992.

    Google Scholar 

  32. Touraine JL, Raudrant D, Royo C, Rebaud A, Roncarolo MG, Souillet G, Philippe N, Touraine F, Betuel H: In-utero transplantation of stem cells in bare lymphocyte syndrome. Lancet 1:1382, 1989.

    Article  PubMed  CAS  Google Scholar 

  33. Flake A, Roncarolo M-G, Puck J, Almeida-Porada G, Evans M, Johnson M, Abella E, Harrison D, Zanjani E: Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 335:1806, 1996.

    Article  PubMed  CAS  Google Scholar 

  34. Wengler G, Lanfranchi A, Frusca T, Verardi R, Neva A, Brugnoni D, Gilliani S, Fiorini M, Mella P, Guandalini F, Mazzolari E, Pecorelli S, Notarangelo L, Porta F, Ugazio A: In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDX1). Lancet 348:1484, 1996.

    Article  PubMed  CAS  Google Scholar 

  35. Gil J, Porta F, Bartolome J, Lafranchi A, Verardi R, Notarangelo LD, Carlo-Stella C, Rodriguez R, Rodriguez JJ, Gurbindo D, Cela E, Zucca A, Fernandez-Cruz E, Ugazio AG Immune reconstitution after in utero bone marrow transplantation in a fetus with severe combined immunodeficiency with natural killer cells.Transplant Proc1999 Sep;31(6):2581).

    Article  PubMed  CAS  Google Scholar 

  36. Touraine J: Treatment of human fetuses and induction of immunological tolerance in humans by in utero transplantation of stem cells into fetal recipients. Acta Haematol 96:115, 1996

    Article  PubMed  CAS  Google Scholar 

  37. Harrison MR, Albanese C, Muench M, Farrell J, Lopoo J, Barcena A: Allogeneic in utero transplantation of CD34+THY-1+ bone marrow derived hematopoietic stem cells (HSC) in a fetus with chronic granulomatous disease. Proceedings of the International Fetal Medicine and Surgery Society. Carlisle, UK, 1999

    Google Scholar 

  38. Alan W. Flake and Esmail D. Zanjani: In Utero Hematopoietic Stem Cell Transplantation: Ontogenic Opportunities and Biologic Barriers. Blood, Vol. 94 No. 7 (October 1), 1999: pp. 2179–2191

    Google Scholar 

  39. Monni G; Ibba RM; Zoppi MA; Floris M: Purified paternal CD34+ HSC at 10 weeks gestation, no engraftment, normal birth. Croat Med J 1998 Jun;39(2):220–223.

    PubMed  CAS  Google Scholar 

  40. Hayward A, Ambruso D, Battaglia F, Donlon T, Eddelman K, Giller R, Hobbins J, Hsia YE, Quinones R, Shpall E, Trachtenberg E, Giardina P: Microchimerism and tolerance following intrauterine transplantation and transfusion for-thalassemia-1. Fetal Diagn Ther 13:8, 1998.

    Article  PubMed  CAS  Google Scholar 

  41. Thalaganthan B, Nicolaides K: Intrauterine bone-marrow transplantation at 12 weeks gestation. Lancet 342:243, 1993.

    Article  Google Scholar 

  42. Flake AW, Zanjani ED: In Utero Transplantation, in Forman SJ, Bloom KG, Thomas ED (eds): Hematopoietic Cell Transplantation (ed 2). Malden, MA, Blackwell Science, 1999, p 444.

    Google Scholar 

  43. Owen RD: Immunogenetic consequences of vascular auestomoses between bovine cattle twins. Science 10:400, 1945

    Article  Google Scholar 

  44. Cragle RG, Stone WH: Preliminary results of kidney grafts between cattle chimeric twins. Transplantation 5:328, 1967

    Article  Google Scholar 

  45. asBillingham RE, Brent L, Madawar PB: Actively acquired tolerance of foreign cells. Nature 4379:603, 1953

    Article  Google Scholar 

  46. Billingham R, Brent L, Madawar PB: Quantitative studies on tissue transplantation immunity. Actively acquired tolerance. Phil Trans Roy Soc(lon) B 239:357, 1956

    Article  Google Scholar 

  47. Renda MC, Fecarotta E, Dieli F, Markling L, Westgren M, Damiani G, Jakil C, Picciotto F, Maggio A: Evidence of alloreactive T lymphocytes in fetal liver: implications for fetal hematopoietic stem cell transplantation.Bone Marrow Transplant2000 Jan;25(2):135–41.

    Article  PubMed  CAS  Google Scholar 

  48. Guidos CJ, Danska JS, Fathman CG, Weissman IL: T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages. J Exp Med. 172(3):835, 1990

    Article  PubMed  CAS  Google Scholar 

  49. Sarzotti M, Robbins DS, Hoffman PM: Induction of protective CU responses in newborn mice by a murine retrovirus. Science 271(5256):1726–1728, 1996

    Article  PubMed  CAS  Google Scholar 

  50. Kappler JW, Roehm N, Marrack P: T cell tolerance by clonal elimination in the thymus. Cell 49(2):273, 1987

    Article  PubMed  CAS  Google Scholar 

  51. Fuchs EJ, Matzinger P: B cells turn off virgin but not memory T cells. Science 258:1156, 1992

    Article  PubMed  CAS  Google Scholar 

  52. Ridge JP, Fuchs EJ, Matzinger P: Neonatal tolerance revisited: Turning on newborn T cells with dendritic cells. Science 271(5256):1723, 1996

    Article  PubMed  CAS  Google Scholar 

  53. Forsthuber T, Yip HC, Lehmann PV: Induction of TH1 and TH2 immunity in neonatal mice. Science 271(5256):1728, 1996

    Article  PubMed  CAS  Google Scholar 

  54. Carrier E, Gilpin E, Lee TH, Busch MP, Zanetti M: Microchimerism does not induce tolerance after in utero transplantation and may lead to the development of alloreactivity.J Lab Clin Med2000 Sep;136(3):22435

    Article  Google Scholar 

  55. Flake A, Zanjani E: Cellular therapy. New trends and controversies in fetal diagnosis and therapy. Obstet Gynecol Clin North Am 24:159, 1997

    Article  PubMed  CAS  Google Scholar 

  56. Stewart FM, Crittenden RB, Lowery PA, Quesenberry PJ et al: Long-term engraftment of normal and post-5-fluorouracil murine bone marrow into normal nonmyeloablated mice. Blood 81:2566, 1993

    PubMed  CAS  Google Scholar 

  57. Quesenberry PJ, Ramshaw H, Crittenden RB et al: Engraftment of normal murine marrow into nonmyeloablated host mice. Blood Cells 20(23):348, 1994

    PubMed  CAS  Google Scholar 

  58. Archer DR, Hester LE, Gu Y et al: Successful in utero engraftment of allogeneic hematopoietic cells in murine a-thalassemia. Blood 92(10):267a, 1998

    Google Scholar 

  59. Barker JE, Compton ST: Hematopoietic repopulation of adult mice with betathalassemia. Blood 83(3):828–832, 1994.

    PubMed  CAS  Google Scholar 

  60. Donahue J, Kuypers F, Witkowska E, Carrier E et al: Engraftment and tolerance following in utero transplantation in ß-thalassemic mice. Blood 92(10):286b, 1998

    Google Scholar 

  61. Hedrick H, Rice H, MacGillivray T, Beater J, Zanjani E, Flake A. Hematopoietic chimerism achieved by in utero hematopoietic stem cell injection does not induce donor-specific tolerance for renal allografts in sheep. Transplantation 1994; 58: 110–111.

    PubMed  CAS  Google Scholar 

  62. Fuchs EJ, Matzinger P. B cells turn off virgin but not memory T cells. Science 1992; 258: 1156–1159.

    Article  PubMed  CAS  Google Scholar 

  63. Matzinger P. Tolerance, danger, and the extended family. Ann Rev Immunol 1994; 12: 991–1045.

    Article  CAS  Google Scholar 

  64. Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited. Science 1996; 271: 1723–1726.

    Article  PubMed  CAS  Google Scholar 

  65. Bambach BJ, Moser HW, Blakemore K, Corson VL, Griffin CA, Noga SJ,Perlman EJ, Zuckerman R, Wenger DA, Jones RJ. Engraftment following in utero bone marrow transplantation for globoid leukodystrophy. Bone Marrow Transplant 1997; 19 (4): 399–402.

    Article  PubMed  CAS  Google Scholar 

  66. Sarzotti M, Robbins DS, Hoffman PM. Induction of protective CTL responses in newborn mice by murine retrovirus. Science 1996; 271: 1726–1728.

    Article  PubMed  CAS  Google Scholar 

  67. Sykes M, Chester GH, Sachs DH. Effect of T-cell depletion in radiation bone marrow chimeras. J Exp Med 1988; 168: 661–668.

    Article  PubMed  CAS  Google Scholar 

  68. Drobyski WR, Majewski D. Donor gamma delta T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice. Blood 1997; 89(3): 1100–1109.

    PubMed  CAS  Google Scholar 

  69. Krenger W, Snyder K, Byon J, Falzarano G, Ferrara J. Polarized type 2 allogeneic CD+ and CD8+ donor T cells failed to induce experimental acute graft-versus-host disease. J Immunol 1995; 155: 585–593.

    PubMed  CAS  Google Scholar 

  70. Fu F, Li Y, Qian S, Lu L, Chambers F, Starzl T, Fung J, Thomson A. Costimulatory molecule-deficient dendritic cell progenitors (MHC II+, CD8Odim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996; 62: 659–665.

    Article  PubMed  CAS  Google Scholar 

  71. Lu L, Li W, Zhong G, Qian S, Fung J, Thomson A, Starzl T. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus antiCD4OL mAb. Transplantation 1999; 68: 747–757.

    Article  PubMed  CAS  Google Scholar 

  72. Lu L, McCaslin D, Starzl T, Thomson A. Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHCII+, B7–1dim, B7–2-) induce alloantigens-specific hyporesponsiveness in murine lymphocytes. Transplantation 1995; 60: 1539–1545.

    Article  PubMed  CAS  Google Scholar 

  73. Kikuchi T, Moore MA, Crystal RG. Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors. Blood 2000; 96: 91–99.

    PubMed  CAS  Google Scholar 

  74. Korbutt GS, Elliott JF, Rajotte RV. Cotransplantation of allogeneic islets with allogenic testicular cell aggregate allows long-term graft survival without systemic immunosuppression. Diabetes 1997; 46: 317–322.

    Article  PubMed  CAS  Google Scholar 

  75. Korbutt GS, Suarez-Pinzon WL, Power RF, Rajjott RV, Rabinovitch A. Testicular sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice. Diabetologia 2000; 43(4): 474–480.

    Article  PubMed  CAS  Google Scholar 

  76. Zhang J, Ma B, Marshak-RotHSCTein A, Fine A. Characterization of a novel cis-element that regulates Fas ligand expression in corneal endothelial cells. J Biol Chem 1999; 274 (37): 26537–26542.

    Article  PubMed  CAS  Google Scholar 

  77. Korbutt GS, Elliott JF, Rajotte RV. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 1997; 46 (2): 317–322.

    Article  PubMed  CAS  Google Scholar 

  78. Minguela A, Marin L, Torio A, Muro M, Garcia-Alonso AM, Moya-Quiles MR, Sanchez-Bueno, Parrilla P, Alvarez-Lopez MR. CD28/CTLA4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant. Hum Immunol 2000; 61(7): 658–669.

    Article  PubMed  CAS  Google Scholar 

  79. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, Mak TW, Sakaguchi S. Immunogenic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192 (2): 303–310.

    Article  PubMed  CAS  Google Scholar 

  80. peptides. I. Correlation of graft survival with anti-donor IgG antibody subclasses. Transplantation 1997; 64: 1665.

    Article  Google Scholar 

  81. Bercovici N, Heurtier A, Vizler C, Pardigon N, Cambouris C, Desreumaux P, Liblau R. Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage.

    Google Scholar 

  82. Overwijk WW, Tsung A, Irvine KR, et al. gp100/pmel 17 is a murine tumor rejection antigen: induction of “self’-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J Exp Med 1998; 188 (2): 277–286.

    Article  PubMed  CAS  Google Scholar 

  83. Saborio DV, Chowdhury NC, Jin MX, Chandraker A, Sayegh MH, Oluwole SF. Regulatory T cells maintain peripheral tolerance to islet allografts induced intrathymic injection of MHC class I allopeptides.

    Google Scholar 

  84. Oluwole SF, Chodhury NC, Fawwaz RA. Induction of donor specific unresponsiveness to rat cardiac allografts by pretreatment with donor MHC class I antigen. Transplantation 1993; 55: 1396.

    Article  PubMed  CAS  Google Scholar 

  85. Liang B, Zhang Z, Inserra P, Jiang S, Lee J, Garza A, Marchalonis J, Watson R. Injection of T-cell receptor peptide reduces immunosenescence in aged C57BL/6 mice. Immunology 1998; 93:462–468.

    Article  PubMed  CAS  Google Scholar 

  86. Yuh DD, Gandy KL, Hoyt G, Reitz BA, Robbins RC. Tolerance to cardiac allografts induced in utero with fetal liver cells. Circulation 1996; 94 (9): 304–307.

    Google Scholar 

  87. Shen Z, Mohiuddin M, DiEssa VJ. Fetal inoculation with donor cells in cardiac xenotransplantation. Ann Thorac Surg 1996; 62 (5): 1360–1363

    Article  PubMed  CAS  Google Scholar 

  88. Henriksson G, Manthorpe R, Bredberg A. Antibodies to CD4 in primary Sjoreri s syndrome. Rheumatology 2000; 39 (2): 142–147.

    Article  PubMed  CAS  Google Scholar 

  89. Ando K, Fugino Y, Mochizuki. Effects of monoclonal antibodies directed at cell surface molecules on murine experimental autoimmune uveoretinitis. Graefes Arch Clin Exp Ophthalmol 1999; 237 (10): 848–854.

    Article  PubMed  CAS  Google Scholar 

  90. Honey K, Gobbold SP, Waldmann H. CD40 ligand blockade induces CD4 positive T cell tolerance and linked suppression. J Immunol 1999; 163 (9): 4805–4810.

    PubMed  CAS  Google Scholar 

  91. Good RA. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases. World J Surg 2000; 24 (7): 797–810.

    Article  PubMed  CAS  Google Scholar 

  92. Marmont AM. Stem cell transplantation for severe autoimmune diseases: progress and problems. Haematologica 1998;83(8): 733–743.

    PubMed  CAS  Google Scholar 

  93. Colman PG, Steele C, Couper JJ, et al. Islet autoimmunity in infant with a type I diabetic relative is common but frequently restricted to one autoantibody.

    Google Scholar 

  94. Rhoads GG, Jackson LG, Schlesselman SE et al: The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med. 320(10):609, 1989

    Article  PubMed  CAS  Google Scholar 

  95. Mychaliska GB, Muench MO, Rice HE et al: The biology and ethics of banking fetal liver hematopoietic stem cells for in utero transplantation. J Ped Surg. 33(2):394, 1998

    Article  CAS  Google Scholar 

  96. The Peel Report. Chairman, Sir Jonathan Peel: The use of fetuses and fetal material for research. London HMSO 1972

    Google Scholar 

  97. The Polkinghorne Report. Chairman, the Rev Dr. John Polkinghorne: Review of the guidance on the research of fetuses and fetal material. London, HMSO, 1989

    Google Scholar 

  98. Anderson F, Glasier A, Ross J, Baird DT: Attitudes of women to fetal tissue research. J Med Ethics 20(1):36, 1994

    Article  PubMed  CAS  Google Scholar 

  99. Fletcher JC: Fetal therapy, ethics and public policies. Fetal Diagn Ther 7(2):158, 1992

    Article  PubMed  CAS  Google Scholar 

  100. McCullough LB, Chervenak FA: Ethics in obstetrics and gynecology. New York, NY. Oxford, University Press, 1994

    Google Scholar 

  101. Chervenak FA, McCullough LB: Does obstetric ethics have any role in the obstetrician’s response to the abortion controversy? Am J Obstet Gynecol. 163(5 Pt 1):1425, 1990

    PubMed  CAS  Google Scholar 

  102. Kingman S, Yamauchi H, Donozyski A et al: Fetal tissue research around the world. BMJ 304(6831):591, 1992

    Article  PubMed  Google Scholar 

  103. Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann N Y Acad Sci 850:251–269, 1998.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Jody Donahue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ewa Carrier
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Blood and Marrow Transplantation Division, University of California, San Diego, USA

    Asad Bashey M.D., Ph.D.  & Edward D. Ball M.D.  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Donahue, J., Carrier, E. (2002). Non-Myeloablative Transplants for Congenital Diseases. In: Bashey, A., Ball, E.D. (eds) Non-Myeloablative Allogeneic Transplantation. Cancer Treatment and Research, vol 110. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0919-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0919-6_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5304-1

  • Online ISBN: 978-1-4615-0919-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation